Strategic Environmental & Energy Resources, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Strategic Environmental & Energy Resources, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.90M | Apr 16, 2024 |
| FY2023 | Dec 31, 2022 | $4.02M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.48M | Apr 14, 2023 |
| FY2018 | Dec 31, 2018 | $8.22M | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | $8.43M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $7.65M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $12.64M | Apr 14, 2017 |
| FY2015 | Dec 31, 2014 | $17.30M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $11.61M | Apr 14, 2015 |
| FY2013 | Dec 31, 2012 | $6.84M | Mar 27, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.31M | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $2.90M | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $4.02M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.48M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.74M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $4.30M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $5.27M | May 15, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.80M) | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | ($2.37M) | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | ($2.64M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $328.9K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($2.76M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.54M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($2.93M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($2.20M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($3.89M) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | ($2.89M) | Apr 14, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.03M) | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | ($1.68M) | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | ($1.43M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($736.3K) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($1.48M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($755.1K) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($657.9K) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($4.77M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($4.76M) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | ($3.38M) | Apr 14, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Apr 14, 2023 |
| FY2020 | Dec 31, 2020 | $0 | Apr 15, 2021 |
| FY2020 | Dec 31, 2019 | $0 | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $600 | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $5.6K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $192.4K | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $491.2K | Apr 14, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.26M | Apr 14, 2023 |
| FY2022 | Dec 31, 2021 | $1.02M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.12M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.48M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $1.31M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $2.52M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $2.03M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $3.03M | Apr 14, 2017 |
| FY2015 | Dec 31, 2014 | $3.29M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $3.89M | Apr 14, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($436.1K) | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | ($937.5K) | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | ($1.02M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.55M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($1.69M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.10M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.00M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($2.79M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($747.8K) | Apr 18, 2018 |
| FY2014 | Dec 31, 2014 | $29.7K | Apr 14, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $22.7K | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $14.9K | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $18.4K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.0K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $131.6K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $70.1K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $60.3K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $199.8K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $163.7K | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $455.0K | Apr 14, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.46M | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $851.0K | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $1.64M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.24M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.22M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.06M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.78M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $3.75M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $6.54M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $7.45M | Apr 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $16.41M | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $14.14M | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $12.55M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.43M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $10.95M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $9.34M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $8.02M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $7.09M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $8.85M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $6.48M | Apr 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($13.00M) | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | ($11.34M) | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | ($8.97M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($6.33M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($6.67M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($4.25M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.81M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($624.7K) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($141.4K) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $2.38M | Apr 14, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $277.8K | Apr 16, 2024 |
| FY2023 | Dec 31, 2022 | $277.8K | Apr 16, 2024 |
| FY2023 | Dec 31, 2021 | $0 | Apr 16, 2024 |
| FY2019 | Dec 31, 2018 | $227.8K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $227.8K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $227.8K | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | $227.8K | Apr 14, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($36.18M) | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | ($34.38M) | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | ($32.01M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($29.36M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($29.69M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($26.96M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($24.41M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($21.47M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($19.27M) | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | ($15.39M) | Apr 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $537.1K | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | $57.9K | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | $21.5K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $188.8K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $46.8K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $354.7K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $115.7K | May 15, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.34M | Jun 6, 2025 |
| FY2023 | Dec 31, 2023 | $8.20M | Apr 16, 2024 |
| FY2022 | Dec 31, 2022 | $5.90M | Apr 14, 2023 |
| FY2021 | Dec 31, 2021 | $6.82M | Apr 15, 2022 |
| FY2020 | Dec 31, 2020 | $3.62M | Apr 15, 2021 |
| FY2019 | Dec 31, 2019 | $4.74M | May 15, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 65.09M | Jun 6, 2025 |
| FY2024 | Dec 31, 2023 | 65.09M | Jun 6, 2025 |
| FY2023 | Dec 31, 2022 | 65.09M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 65.09M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 65.09M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 65.09M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 61.70M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 56.53M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 54.53M | Apr 18, 2018 |
| FY2016 | Dec 31, 2015 | 52.38M | Apr 14, 2017 |